Nissay Asset Management Corp Dexcom Inc Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Dexcom Inc stock. As of the latest transaction made, Nissay Asset Management Corp holds 101,534 shares of DXCM stock, worth $7.74 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

101,534

Previous 92,878 9.32%

Holding current value

$7.74 Million

Previous $10.5 Million 35.38%

% of portfolio

0.04%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $553,984 - $1 Million	8,656 Added 9.32%	101,534 $6.8 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $987,605 - $1.26 Million	8,953 Added 10.67%	92,878 $10.5 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $1.86 Million - $2.28 Million	16,289 Added 24.08%	83,925 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $358,351 - $589,387	4,747 Added 7.55%	67,636 $8.39 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $303,533 - $486,479	3,527 Added 5.94%	62,889 $5.87 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $53,535 - $62,346	476 Added 0.81%	59,362 $7.63 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $1.33 Million - $1.57 Million	-12,778 Reduced 17.83%	58,886 $6.84 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $543,447 - $784,474	6,395 Added 9.8%	71,664 $8.12 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $159,495 - $196,742	2,089 Added 3.31%	65,269 $5.26 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $3.32 Million - $6.5 Million	48,884 Added 341.94%	63,180 $4.71 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $24,178 - $33,461	257 Added 1.83%	14,296 $7.31 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $142,727 - $178,939	1,099 Added 8.49%	14,039 $7.54 Million
Q3 2021 Nov 10, 2021	BUY	$106.71 - $143.18 $46,205 - $61,996	433 Added 3.46%	12,940 $7.08 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $202,798 - $270,256	2,504 Added 25.03%	12,507 $5.34 Million
Q1 2021 May 11, 2021	SELL	$84.79 - $104.74 $17,551 - $21,681	-207 Reduced 2.03%	10,003 $3.6 Million
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $7,722 - $10,345	99 Added 0.98%	10,210 $3.78 Million
Q3 2020 Oct 20, 2020	SELL	$95.51 - $112.95 $176,884 - $209,183	-1,852 Reduced 15.48%	10,111 $4.17 Million
Q2 2020 Jul 27, 2020	BUY	$62.68 - $105.34 $54,468 - $91,540	869 Added 7.83%	11,963 $4.85 Million
Q1 2020 May 05, 2020	BUY	$47.79 - $75.63 $28,817 - $45,604	603 Added 5.75%	11,094 $2.99 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $111,910 - $175,078	3,056 Added 41.1%	10,491 $2.3 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $15,562 - $19,184	438 Added 6.26%	7,435 $1.11 Million
Q2 2019 Aug 07, 2019	SELL	$27.84 - $38.92 $22,299 - $31,174	-801 Reduced 10.27%	6,997 $1.05 Million
Q1 2019 May 03, 2019	BUY	$28.07 - $38.18 $11,817 - $16,073	421 Added 5.71%	7,798 $929,000
Q4 2018 Feb 06, 2019	BUY	$26.99 - $37.37 $199,105 - $275,678	7,377 New	7,377 $884,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Dexcom Inc Transaction History